Skip to content

HLG

Active Risk: very low
Private limited companyfounded 2018active for 8 yearsSynaps Park 1, 3600 Genk, Belgium53 active companies are registered at this addressKBO/BCE: BE 0697.858.283
Summary

HLG has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,600. Equity is growing by about 7.7% per year across the filed financial years. Its solvency ranks better than 5% of 2,939 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
2 sites
Size
€5.7mtotal assets 2025
Equity
€18,600
Financial health
Bankruptcy probabilitywithin 12 months
< 0.1%
Too few figures to score
Structure
Largest shareholder
CARDIOLOGIE PIETER MARTENS · 50%
Board
4 members
  • BV Matthias DupontManaging director
Accounts 16 days early1 of 6 deeds read
Signalsraises riskEquity €18,600 (0.3% of total assets)Weak solvency vs sectorlowers riskSector: Human health activities (NACE 86)Size: total assets €5.7mFigures for financial year 2025 (filed 15-07-2026)neutralLatest accounts filed on timeShow the evidence

Bankruptcy probability

No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,071 companies, NACE 86, small)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.3%▲ +0.1 percentage points vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.1%▼ -0.3 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: < 0.1%▼ -0.1 percentage points vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €5.7m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €18,600 (0.3% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 15-07-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 2939 sector peers (2025).
NBB · sector comparison
Position among 2939 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
16 days early
2024
on the day
2023
27 days late
2022
8 days late
2021
31 days late
2020
27 days late
2019
69 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 21 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
12-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Resignations: BV DR VANDERVOORT, BV VISCOR…Permanent representatives: VANDERVOORT Pieter, FERDINANDE…
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Caution: Among the weakest 5% on solvencysector median 59.1% · 2,939 companies 0.3% View
  • Board changedlatest change 08-01-2026 · 4 in office 4 joined · 1 left View
  • Total assets 20256 financial years filed €5.7m View

By topic

Financials

Financial year
2025
Total assets
€5.7m
Solvency
0.3%
Liquidity
600.69
Turnover▲ 14.8%
Net result
20212023
Go to Financials

Board & ownership

Board
4 members
Largest shareholder
CARDIOLOGIE PIETER MARTENS · 50%
  • BV Dokter Yves CruysberghsDirector
  • BV DR. Ph. BertrandDirector
  • BV Matthias DupontManaging director
  • BV VISCORDirector
Go to Board & ownership

Timeline

Events
12
Since
2019
Next accounts
by 31-07-2027
  1. 27-08-2024Annual accounts filed
  2. 08-08-2023Annual accounts filed
  3. 31-08-2022Annual accounts filed
Go to Timeline

Company details

Sites
2
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
31-05-2018
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.